Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

VC Roundup: Early-Stage Funding Slips Again In Third Quarter, Plus 15 New Financings

Executive Summary

Early-stage venture capital funding continues to decline, but corporate VC dollars and other sources of cash are emerging to fund startups. Also, biopharma companies raised $436.3m in 15 recent financings.


Related Content

Billions On The Line With Celgene’s Partnered Pipeline
Venture Funding Deals: ADC Therapeutics, Unity Biotech Raise $100m-Plus
VC Roundup: October Brings Several New Venture Funds, Including Third Rock’s Fourth
Carrick Therapeutics Lays Foundation For 'Leading Oncology Business'
US/China-based MicuRx Gets $55m Series C Funding For MRX-I Antibiotic
Deal Watch: Allergan Deal-Binge Includes Derm, NASH Buys
Artios Launches With £25m To Study ‘PARP-esque’ DNA Damage Response Inhibitors
Deal Watch: Pfizer, BioAtla Team Up To Develop Targeted Antibody Oncologics
BioNotebook: PhaseBio closes $40m Series C round led by AstraZeneca, plus five other VC financings
Cancer drug start-up Peloton raises $18M


Related Companies